|
Mind Medicine (MindMed) Inc. (MNMD) DCF Valuation
CA | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Mind Medicine (MindMed) Inc. (MNMD) Bundle
Gain mastery over your Mind Medicine (MindMed) Inc. (MNMD) valuation analysis using our sophisticated DCF Calculator! This Excel template comes preloaded with actual MNMD data, enabling you to adjust forecasts and assumptions for an accurate calculation of Mind Medicine's intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -1.1 | -33.8 | -91.2 | -53.6 | -92.6 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | .0 | .2 | 2.6 | 3.2 | 3.2 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -1.1 | -34.0 | -93.8 | -56.8 | -95.7 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | .0 | 80.1 | 133.5 | 142.1 | 99.7 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | .0 | 2.0 | 4.2 | 2.1 | 4.1 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | -.3 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -1.1 | -34.1 | -92.7 | -47.3 | -95.7 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -1.4 | -31.9 | -87.9 | -46.1 | -90.5 | -4.1 | .0 | .0 | .0 | .0 |
WACC, % | 14.91 | 14.91 | 14.9 | 14.87 | 14.91 | 14.9 | 14.9 | 14.9 | 14.9 | 14.9 |
PV UFCF | ||||||||||
SUM PV UFCF | -3.6 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -4 | |||||||||
Net Debt | -86 | |||||||||
Equity Value | 82 | |||||||||
Diluted Shares Outstanding, MM | 39 | |||||||||
Equity Value Per Share | 2.09 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-filled real MNMD financials.
- Accurate Data: Historical performance data and forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect Mind Medicine’s valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Interface: Organized for clarity and ease of navigation, complete with step-by-step guidance.
Key Features
- Real-Life MNMD Data: Pre-filled with Mind Medicine’s historical financials and forward-looking projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
- Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
- User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based MNMD DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key factors.
- Instant Calculations: The model automatically recalculates Mind Medicine’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Leverage the results to inform your investment or financial analysis.
Why Choose This Calculator for Mind Medicine (MindMed) Inc. (MNMD)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your analytical needs.
- Real-Time Valuation: Instantly observe changes in MindMed’s valuation as you tweak inputs.
- Preloaded Data: Comes equipped with MindMed’s latest financial metrics for swift evaluations.
- Relied Upon by Experts: Employed by investors and analysts to guide strategic decisions.
Who Should Use This Product?
- Investors: Accurately assess Mind Medicine’s fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to MindMed (MNMD).
- Consultants: Efficiently tailor the template for valuation reports for clients focusing on MindMed (MNMD).
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
- Educators: Implement it as a teaching resource to illustrate valuation methodologies in the biotech sector.
What the Template Contains
- Preloaded MNMD Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.